Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Vevo Therapeutics logo — We are combining in vivo data and AI to find better targets...

Vevo Therapeutics

We are combining in vivo data and AI to find better targets and drugs that can treat more patients.

Founded 2022 25 employees Seed Total: $12.00M AI, Biotechnology +1

General Information

Company Name Vevo Therapeutics
Founded Year 2022
Employees 25
Industries AI, Biotechnology, Health and Wellness
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Vevo Therapeutics. To contact Vevo Therapeutics, visit vevo.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Vevo Therapeutics compare?

A PDF of Vevo Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Vevo Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Vevo Therapeutics

Vevo Therapeutics is a biotechnology startup founded in 2022, with a mission to revolutionize drug discovery using in vivo data and AI. The company's Mosaic platform is pioneering in capturing in vivo context of diseases with single-cell precision, enabling a more accurate representation of patient diversity in drug response. Vevo aims to build the world's largest in vivo atlas of drug interactions with patient cells using this platform. The company is based in San Francisco, CA and is backed by prominent investors in the life sciences and technology sectors, including Wing Venture Capital, General Catalyst, AIX Ventures, Camford Capital, and Mubadala Capital, who collectively participated in a $12.00M Seed Round investment on 08 December 2022. Vevo Therapeutics stands at the forefront of leveraging cutting-edge technology to discover novel drug targets and develop treatments with the potential to benefit a wider range of patients in the biotechnology industry. Learn more at www.vevo.ai.

Business keywords: in vivo data, drug discovery, Mosaic platform, single-cell precision, patient diversity, in vivo atlas, genomics, computational biology, chemistry, San Francisco, investors, life sciences, technology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $12.00M 5
Wing VC General Catalyst AIX Ventures
Wing VC, General Catalyst +3
08 Dec 2022

Vevo Therapeutics Alternatives & Competitors

View All Alternatives
Vevo Therapeutics vs
Trellis Bioscience Inc.
Trellis Bioscience Inc. United States

Our human mAb TRL1068 disrupts bacterial biofilm and makes traditional antibiotics work again overco...

Grant
18 employees
Biotechnology, Health Care
Compare Vevo Therapeutics vs Trellis Bioscience Inc.
Vevo Therapeutics vs
Bainom
Bainom United States

Unlocking clinical insights by decoding intricate multi-omic patterns.

Pre-Seed
2 employees
AI, Analytics
Compare Vevo Therapeutics vs Bainom
Vevo Therapeutics vs
Nine Square Therapeutics
Nine Square Therapeutics United States

A quest to alter the trajectory of neurodegenerative disease

Grant
27 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About Vevo Therapeutics

We are combining in vivo data and AI to find better targets and drugs that can treat more patients.
Vevo Therapeutics was founded in 2022.
Vevo Therapeutics operates in AI, Biotechnology and Health and Wellness. Its work centres on in vivo data, drug discovery, Mosaic platform and single-cell precision.
Vevo Therapeutics has approximately 25 employees.
Vevo Therapeutics has completed 1 funding round, raising a total of $12.00M. The latest funding stage is Seed.
Top alternatives and competitors to Vevo Therapeutics include Trellis Bioscience Inc., Bainom, Nine Square Therapeutics, Mosaic TX, MNM Bioscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vevo Therapeutics and Trellis Bioscience Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Vevo Therapeutics, https://bouncewatch.com/company/vevo-therapeutics, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout